Keywords
amyotrophic lateral sclerosis
neurodegenerative disease
neurodegenerative disease
How to Cite
Landa Alberdi, J., Leunda Eizmendi, L., Ercilla Liceaga, M., Umerez Igartua, M., Lizardi Mutuberria, A., Garcia de Andoin Barandiaran, M. J., & Urretavizcaya Anton, M. (2019). Amyotrophic lateral sclerosis. Osagaiz: Osasun-Zientzien Aldizkaria, 3(2). Retrieved from https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/275
Abstract
Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal neurodegenerative disease of the human motor system, causing muscle weakness, which can lead to paralysis. Patients can present difficulties in oral communication, swallowing, motor autonomy and breathing. However, sensitivity, sphincter control and eye muscles’ activity are preserved. It’s an incurable disease, and there is only one drug in the market that can extend longevity: riluzole. The life expectancy is short, causing death within 4-5 years in most patients.